These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 5931752)
21. The tumour-inhibiting effect of properdin. Pfordte K; Ponsold W Neoplasma; 1969; 16(6):609-12. PubMed ID: 5369027 [No Abstract] [Full Text] [Related]
22. General pharmacological profile of the new cognition-enhancing agent nefiracetam. Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090 [TBL] [Abstract][Full Text] [Related]
23. [Studies on properdin]. Pfordte K Z Naturforsch B; 1966 Jan; 21(1):56-8. PubMed ID: 4382384 [No Abstract] [Full Text] [Related]
24. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human). Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970 [TBL] [Abstract][Full Text] [Related]
25. Three isoforms of complement properdin factor P in trout: cloning, expression, gene organization and constrained modeling. Chondrou M; Papanastasiou AD; Spyroulias GA; Zarkadis IK Dev Comp Immunol; 2008; 32(12):1454-66. PubMed ID: 18638502 [TBL] [Abstract][Full Text] [Related]
26. [Levels of properdin in the serum of rats submitted to the combined effect of zymosan and thio-TEPA]. Bass-Shadkhan KhF Klin Lech Zlokach Novoobraz; 1968; 11():227-36. PubMed ID: 4972953 [No Abstract] [Full Text] [Related]
27. [Determination of properdin in the blood serum]. Pogrebniak LL; Svetlova LL; Truzhnikova TM; Ushchenko ID Veterinariia; 1975 Aug; (8):84-6. PubMed ID: 1216645 [No Abstract] [Full Text] [Related]
28. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide. Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167 [TBL] [Abstract][Full Text] [Related]
29. [The effect of UV irradiation on serum properdin levels in vitro]. Pfordte K Strahlentherapie; 1966 Jul; 130(3):459-63. PubMed ID: 5991739 [No Abstract] [Full Text] [Related]
30. [Relations between properdin and tumor resistance]. Pfordte K Z Gesamte Hyg; 1970 Jun; 16(6):450-8. PubMed ID: 5512283 [No Abstract] [Full Text] [Related]
31. [Relation between zymosan, properdin & tumors. 2. Behavior of properdin level in rats with benzpyrene-induced sarcomas]. MODICA F; FUMAROLA D Tumori; 1958; 44(6):549-54. PubMed ID: 13635873 [No Abstract] [Full Text] [Related]
32. Alterations in serum properdin levels following injection of Zymosan. PILLEMER L; ROSS OA Science; 1955 May; 121(3151):732-3. PubMed ID: 14372981 [No Abstract] [Full Text] [Related]
33. Effect of repeated zymosan injection upon retention of inhaled particles in rats. LF-41. Thomas RG Fission Prod Inhal Proj; 1969 Nov; ():101-4. PubMed ID: 5310160 [No Abstract] [Full Text] [Related]
34. [Effect of UV irradiation on nonspecific control of infection, especially on the properdin-complement system]. Reissmann G Arch Phys Ther (Leipz); 1965; 17(2):95-8. PubMed ID: 5853657 [No Abstract] [Full Text] [Related]
35. [Effect of methyluracil on the activity of blood serum properdin system of intact and irradiated rabbits]. Danilova TG Radiobiologiia; 1969; 9(4):620-2. PubMed ID: 5375447 [No Abstract] [Full Text] [Related]
36. [Changes in the level of properdin in the blood serum of irradiated and non-irradiated white mice in experimental lymphocytic choriomeningitis]. REMEZOV PI; IAKOVLEVA SD Vopr Virusol; 1960; 5():431-5. PubMed ID: 13740747 [No Abstract] [Full Text] [Related]
38. [Interrelations of zymosan, properdin & tumors. IV. Behavior of mucopolysaccharides in the blood in benzopyrene sarcoma-bearing rats]. MODICA F Tumori; 1959; 45(1):54-9. PubMed ID: 13659610 [No Abstract] [Full Text] [Related]
39. [Agglutination titer of isoagglutinins in blood serum in cases of malignant neoplasms following zymosan stimulation]. Dobrek A; Maciejewski B; Majewski S Pol Tyg Lek; 1975 Jan; 30(3):93-6. PubMed ID: 1110955 [No Abstract] [Full Text] [Related]
40. [Influence of ultraviolet rays on endogenous resistance with special consideration of the properdin system]. Pfordte K; Ponsold W Strahlentherapie; 1967 May; 133(1):149-57. PubMed ID: 5584670 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]